The DCCT (Diabetes Control and Complications Trial) (64) and its long-term follow-up, the EDIC (Epidemiology of Diabetes Interventions and Complications) study, provide the strongest evidence that intensive insulin therapy significantly reduces the risk of long-term complications. Here, INS is linked to diabetes mellitus.